2010 Annual Scientific Meeting and Exposition 2010 Annual ...

Saturday Afternoon MAY 1PostersPO-70: 3PO-71: 3PO-72: 3PO-73: 3PO-74: 3PO-75: 3PO-76: 2Attenuation of Exercise-Induced Rise in SystolicBlood Pressure by the Direct Renin InhibitorAliskirenBryan Williams†, 1 Fabio Baschiera, 2 Peter S. Lacy, 1Jaco Botha, 2 Patrick Brunel. 2 1 Department ofCardiovascular Sciences, University of Leicester,Leicester, GB and 2 Novartis Pharma AG, Basel, CH.Initial Use of Combination Aliskiren/Valsartanis More Effective than Either ComponentMonotherapy in Elderly and Non-elderlyHypertensive PatientsSteven A. Yarows†, 1 S. Oparil, 2 S. Patel, 3 M. Wright, 4A. Yadao, 3 J. Zhang. 3 1 Chelsea Internal Medicine/IHA,MI, US; 2 UAB Vascular Biology and HypertensionProgram, AL, US; 3 Novartis PharmaceuticalsCorporation, NJ, US and 4 Novartis Pharma AG, CH.Initial Use of the Aliskiren/Valsartan Combinationis More Effective than Either ComponentMonotherapy in Hypertensive Patients with DiabetesSteven A. Yarows†, 1 S. Oparil, 2 S. Patel, 3 M. Wright, 4A. Yadao, 3 J. Zhang. 3 1 Chelsea Internal Medicine/IHA,MI, US; 2 UAB Vascular Biology and HypertensionProgram, AL, US; 3 Novartis PharmaceuticalsCorporation, NJ, US and 4 Novartis Pharma AG, CH.Initial Use of the Aliskiren/Valsartan Combinationis More Effective than Either ComponentMonotherapy in Obese and Non-Obese HypertensivePatientsSteven A. Yarows†, 1 S. Oparil, 2 S. Patel, 3 M. Wright, 4A. Yadao, 3 J. Zhang. 3 1 Chelsea Internal Medicine/IHA,MI, US; 2 UAB Vascular Biology and HypertensionProgram, AL, US; 3 Novartis PharmaceuticalsCorporation, NJ, US and 4 Novartis Pharma AG, CH.The Treatment of Renal Endothelium Dysfunctionin Scleroderma: Telmisartan Effects vs RamiprilRoman I. Yatsyshyn, Natalya G. Yatsyshyn, Yevgen M.Neyko. Ivano-Frankivsk National Medical University,Ivano-Frankivsk, UA.Telmisartan Brain Protection in CRDH Ratsas Revealed by Magnetic Resonance Imaging isBestowed to Adiponectin IncreaseFiras M. Younis, 1 Tamar Blumenfeld-Katzir, 2 TalmaRosenthal. 1 1 Tel Aviv University, Ramat Aviv, Tel Aviv,IL and 2 Tel Aviv University, Ramat Aviv, Tel Aviv, IL.Plasma Renin Efficiency, a Derived Metric ofBiomarker Response, and Its Relation to BPLowering in Hypertensive Patients on AliskirenTreatment: A Pooled Analysis Using Data from NineClinical TrialsRamesh Sarangapani†, 1 William Ebling, 2 Deborah L.Keefe. 1 1 Novartis Pharmaceuticals Corporation, EastHanover, NJ, US and 2 Emergent Insights, Newark, DE,US.1 Pathobiology Track 2 Translational Track 3 Therapy Track115